Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Decrease in Proportion of CD19+CD24hiCD27+ B Cells and Impairment of Their Suppressive Function in Graves’ Disease

  • Bingbing Zha ,

    Contributed equally to this work with: Bingbing Zha, Luman Wang

    Affiliations Department of Endocrinology and Metabolism, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China, Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

  • Luman Wang ,

    Contributed equally to this work with: Bingbing Zha, Luman Wang

    Affiliation Department of Immunology and Biotherapy Research Center, Shanghai Medical College, Fudan University, Shanghai, China

  • Xiaoming Liu,

    Affiliation Department of Immunology and Biotherapy Research Center, Shanghai Medical College, Fudan University, Shanghai, China

  • Jun Liu,

    Affiliation Department of Endocrinology and Metabolism, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  • Zaoping Chen,

    Affiliation Department of Endocrinology and Metabolism, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  • Jiong Xu,

    Affiliation Department of Endocrinology and Metabolism, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  • Li Sheng,

    Affiliation Department of Endocrinology and Metabolism, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  • Yiming Li ,

    yiwei_chu@126.com (YC); yimingli@fudan.edu.cn (YL)

    Affiliation Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

  • Yiwei Chu

    yiwei_chu@126.com (YC); yimingli@fudan.edu.cn (YL)

    Affiliation Department of Immunology and Biotherapy Research Center, Shanghai Medical College, Fudan University, Shanghai, China

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.